Standard BioTools adopts enhanced executive severance plans with change-of-control protections through 2028

Filed May 28, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

• high

  CEO Michael Egholm receives separate severance plan with 250% of salary plus bonus if terminated after a change of control, plus 30 months health coverage—more generous than other executives' 150% package.

  Item 5.02 verify on EDGAR →
• high

  CFO Alex Kim and Chief Business Officer Sean Mackay entered new severance agreements providing 150% of salary plus bonus as lump sum if terminated within 12 months after a change of control, replacing prior 2024 arrangements.

  Item 5.02 verify on EDGAR →
• medium

  Executives terminated by August 27, 2026 receive 100% equity vesting acceleration even outside change-of-control scenarios, creating near-term retention incentive during potential strategic transition period.

  Item 5.02 verify on EDGAR →